Lecture 8: Neoplasia II Flashcards
Examples of causes of cancer
Smoking
Diet, overweight and obesity
Lack of exercise
Viruses
Alcohol
UV and ionizing radiation
Occupational carcinogens
Smoking cessation and cancer progression
See figure
Example of cancer vaccine
HPV 6, 11, 16, and 18 associated with 70% of cervical cancers in women; also anal and mouth cancers
Nobel prize for zur Hausen in 2008
“Gardasil” is available for teen girls (prevention) but uptake is too low
Now including teen boys in Manitoba
Points for cancer control
Prevention
Early diagnosis
Therapies for primary tumor
Therapies for systemic disease (metastases)
Palliative care
Cancer diagnostic tests
Blood, urine, ascites fluid for biomarkers
Blood in urine / feces
Biopsy of tumor/lymphnodes (fine needles aspirates; multi-needle biopsy cores)
Cytology of cells scraped (eg.Papsmear)
Imaging (X-ray, MRI, PET, CT)
Palpation
Common tumour biomarkers
Ovarian cancer: CA-125
Prostate cancer: PSA
Colorectal cancer: CEA, K-ras
Breast cancer: ER, PR, HER2
Testicular cancer: AFP, hCG
How are tumour biomarkers used?
Diagnosis—to confirm the results of other tests and symptoms
Prognosis—to predict the cancer’s behavior, response to treatment, and chance of recovery
Monitor treatment—to determine how the cancer is responding to treatment
Surveillance—to determine whether the cancer has returned after treatment (relapse)
Screening—to find cancer in healthy or high-risk people before symptoms develop
What do tumour grading systems rely on?
pathologists’ assessment of:
cell differentiation
nuclear abnormality
size
shape
proportion of involvement
What is the TNM staging system?
uses information from biopsy, surgery, imaging to assign clinical stage based on usual clinical course (prognosis and therapy)
T [tumor] 1,2,3,or 4 - primary tumor site based on size,
number, location, vascular invasion
N [node] 0 or 1 - metastasis in regional lymph node
M [metastases] 0 or 1 - metastasis in distant organ / tissue
Growth factor receptors
All are cross-membrane proteins with an extracellular domain and their cytoplasmic tyrosine kinase domain in the cytosol
Cancers can overexposes these receptors and ligands
EGF receptor (cysteine rich domain)
IGF-1 receptor (has cysteine bonds in extracellular portion)
PDGF receptor
NGF receptor
FGF receptor
VEGF receptor (has Ig-like extracellular domain)
See figures
Example of nuclear hormone receptors
Half of breast cancers express Estrogen Receptor (ER)
Over 70% of prostate cancers express Androgen Receptor (AR)
Receptor antagonists in ER positive breast cancers
ER positive breast cancers can be treated with receptor antagonists (such as tamoxifen) or aromatase inhibitors (block estrogen production)
Receptor antagonists in AR positive prostate cancers
AR positive prostate cancers can be treated with receptor antagonists (such as flutamide) or GnRH agonists (block androgen production)
Bcr-Abl fusion
Philadelphia
Occurs in leukaemia cells
Part of Bcr gene from chr 22 is translocated to All gene on chr 9
creates fused Bcr/Abl gene, which is transcripts into mRNA, which is translated into protein
See figure
Example of tumour grading and staging
Gleason grade in prostate cancer is most aggressive form